Physician
General Surgery
Dr. Kenneth R. Sirinek, MD
Kenneth Sirinek practices General Surgery. He studied medicine at Medical College of Wisconsin. Medical College of Wisconsin is ranked 54/62 in Research/PrimaryCare. He received awards:"CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACS)". Kenneth Sirinek is also published. He has 101 publications published. The lastest publication: "Simultaneous isoproterenol affords cardiodynamic advantages during vasopressin administration.' Kenneth Sirinek accepts Medicare payments and is registered with Medicare.gov.
Publications
- Has Intraoperative Cholangiography during Laparoscopic Cholecystectomy Become Obsolete in the Era of Preoperative Endoscopic Retrograde and Magnetic Resonance Cholangi...
- Geographic maldistribution of general surgery PGYI residents: another US surgical desert.
- The general surgery workforce shortage is worse when assessed at county level.
- Tort reform is associated with significant increases in Texas physicians relative to the Texas population.
- Absorption and diuretic effects of nebulized ethanol in dogs.
- Nonspecific recurrent jejunal ulceration.
- Gangrenous Cholecystitis in the decade before and after the introduction of laparoscopic cholecystectomy.
- Long-term outcomes in laparoscopic vs open ventral Hernia repair.
- A successful application of the intraoperative parathyroid hormone assay in tertiary Hyperparathyroidism.
- Parathyroidectomy in secondary Hyperparathyroidism: Is there an optimal operative management?
- Nondiagnostic Thyroid fine-needle aspiration biopsies are no longer a dilemma.
- Malpractice risk and cost are significantly reduced after tort reform.
- The Mirizzi syndrome: multidisciplinary management promotes optimal outcomes.
- Gallbladder perforation: risk factors and outcome.
- Early conversion for gangrenous Cholecystitis: impact on outcome.
- Primary duodenal tumors: a diagnostic and therapeutic dilemma.
- Isoproterenol in offsetting adverse effects of vasopressin in cirrhotic patients.
- Simultaneous isoproterenol affords cardiodynamic advantages during vasopressin administration.
- Augmented gastric inhibitory polypeptide response to intraduodenal glucose by exogenous gastrin and cholecystokinin.
- The peak plateau gastric acid response of the Heidenhain pouch to pentagastrin: a new concept.
- Renal effects on serum gastric inhibitory polypeptide (GIP).
- Diagnosis, surgical management and prognosis of toxic megacolon, a complication of Ulcerative colitis.
- Adverse effect of dopamine on portal venous pressure.
- The portal hypertensive effect of dopamine.
- Adverse cardiodynamic effects of vasopressin not avoided by selective intra-Arterial administration.
- Intra-Arterial vasopressin administration complicated by adverse cardiodynamic effects.
- Total proctocolectomy and ileostomy: procedure of choice for acute toxic megacolon.
- Mannitol and glucose: effects on gastric acid secretion and endogenous gastric inhibitory polypeptide (GIP).
- Cimetidine prevents reduction in gastric mucosal blood flow during shock.
- Effect cimetidine on gastric secretory function during stress.
- Insulin-induced attenuation of glucose-stimulated gastric inhibitory polypeptide secretion.
- A fat-enriched meal augments gastric inhibitory polypeptide and suppresses gastrin concentrations.
- Sympathetic neuroendocrine regulation of gastric inhibitory polypeptide response to glucose.
- Cimetidine prevents stress-induced gastric erosions.
- Histamine receptor control of gastric microvasculature in shock.
- Effect of vasopressin on portal pressure during volume replacement after acute hemorrhage.
- Cimetidine affords protection equal to antacids in prevention of stress ulceration following thermal injury.
- Superior mesenteric artery syndrome in thermally injured patients.
- Cimetidine protects against stress-induced gastric injury augmented by mucosal barrier breakers.
- The role of cimetidine in the prevention of stress induced gastric mucosal injury.
- Selective release of gastric inhibitory polypeptide by some actively transported, structurally similar carbohydrates.
- Efficacy of tangential excision and immediate autografting of deep second-degree burns of the hand.
- Wound excision to fascia in burn patients.
- Release of gastric inhibitory polypeptide: comparison of glucose and fat as stimuli.
- The effect of vasopressin on portal hypertension following hepatectomy.
- Glucagon enhances growth of cultured human coloRectal cancer cells in vitro.
- Traumatic injury to the proximal superior mesenteric vessels.
- Early phase of Pancreatic polypeptide release is augmented by calcium infusion.
- Neurotensin, vasoactive Intestinal peptide, and Roux-en-Y gastrojejunostomy. Their role in the dumping syndrome.
- Iatrogenic Vascular injury. A reducible problem.
- Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells.
- Civilian Vascular trauma of the upper extremity.
- Topical prostaglandin E2 in the treatment of acute upper gastroIntestinal tract hemorrhage. A prospective, randomized, double-blind study.
- Portasystemic shunting remains the procedure of choice for control of variceal hemorrhage.
- Transplant site affects splenic T- and B-cell survival and function.
- Improving survival in patients with cirrhosis undergoing major Abdominal operations.
- Direct portacaval anastomoses are safe and effective in patients with previous Abdominal operations.
- Elevated levels of fasting and glucose-stimulated Pancreatic polypeptide in patients with duodenal ulcer.
- Evaluation of gastric adenocarcinoma. Abdominal computed tomography does not replace celiotomy.
- The physiology of postvagotomy duodenal ulcer healing: a prostaglandin connection.
- Antimicrobial management of surgically treated gangrenous or perforated Appendicitis: comparison of cefoxitin and clindamycin-gentamicin.
- Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass.
- Gastric deVascularization.
- High-dose vasopressin for acute variceal hemorrhage. Clinical advantages without adverse effects.
- The asymptomatic Pancreatic islet cell tumor: a novel presentation.
- Effects of gastrin, glutamine, and somatostatin on the in vitro growth of normal and malignant human gastric mucosal cells.
- Pancreatic islet hormone response to oral glucose in morbidly obese patients.
- Percutaneous transhepatic cholangiography and Biliary decompression. Invasive, diagnostic, and therapeutic procedures with too high a price?
- von Hippel-Lindau syndrome presenting as Pancreatic endocrine insufficiency: a case report.
- Simultaneous infusion of nitroglycerin and nitroprusside to offset adverse effects of vasopressin during portosystemic shunting.
- Pancreatic Cancer: continuing diagnostic and therapeutic dilemma.
- Is exploratory celiotomy necessary for all patients with truncal stab wounds?
- The portacaval shunt. Is it still indicated?
- Vagotomy effect on gastric prostaglandins. Primarily neural or Secondary to hypoacidity?
- Management of intraAbdominal infections.
- A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated Appendicitis.
- Variceal rebleeding after portosystemic shunting. Strategies and solutions to a vexing problem.
- Glucose intolerance and hyperinsulinemia of cirrhosis are not results of spontaneous or surgical portosystemic shunting.
- Multiple endocrine neoplasia type IIB identified by magnetic resonance imaging.
- Biliary pancreatitis. Operative outcome with a selective approach.
- Virulent diverticular Disease in young obese men.
- Peripheral vasopressin for safe and adequate control of portal hypertension during shunt operations.
- Isoproterenol added during vasopressin administration provides cardiodynamic advantages.
- Release of gastric inhibitory polypeptide: comparison of hyperosmolar carbohydrate solutions as stimuli.
- Should vasopressin be administered before, during or after volume replacement?
- Intravenous vasopressin in patients with portal hypertension: advantages of continuous infusion.
- A series of 20 successful Warren shunts.
- Abdominal pain and vomiting in a middle-aged woman.
- Open Rives-Stoppa ventral Hernia repair made simple and successful but not for everyone.
- Does the correlation of acute Cholecystitis on ultrasound and at surgery reflect a mirror image?
- Laparoscopic cholecystectomy for Biliary dyskinesia: correlation of preoperative cholecystokinin cholescintigraphy results with postoperative outcome.
- Intraoperative paraThyroid hormone assay: an accurate predictor of symptomatic hypocalcemia following Thyroidectomy.
- Laparoscopic cholecystectomy for elderly patients: gold standard for golden years?
- Roundtable discussion of antibiotic therapy in surgical infections.
- Diagnosis and treatment of intra-Abdominal abscesses.
- Reasons for conversion from laparoscopic to open cholecystectomy: a 10-year review.
- Operations for peptic ulcer Disease: paradigm lost.
- Bidirectional endoscopy in patients with fecal occult blood.
- Jejunoileal causes of overt gastroIntestinal bleeding: diagnosis, management, and outcome.
- Treatment of acute Cholecystitis in non-critically ill patients at high surgical risk: comparison of clinical outcomes after gallbladder aspiration and after percutane...
Schools
Marquette School Of Medicine
Ohio St University College Med
Procedures Preformed
- Appendectomy, Laparoscopic
- Appendectomy, Open
- Biliary Drainage
- Colectomy
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- Anal Fissure
- Appendicitis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACS)
Education
-
Ohio State University Hospital -
Medical College of Wisconsin
Hospital
-
University Health System
Drug Facts
| NPI NUMBER | 1558379891 | |
| NPPES Provider LastName | SIRINEK | |
| NPPES Provider FirstName | KENNETH | |
| NPPES Provider ZIPCode | 782293931 | |
| NPPES Provider State | TX | |
| Specialty Description | General Surgery | |
| Total Claim Count | 47.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 38.3 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1558379891 |
| Last Name Of The Provider | SIRINEK |
| First Name Of The Provider | KENNETH |
| View All |
Similar Doctors
|
Dr. Brian S. Castillo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joe E. Johnston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francis J. Harford Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bernard S. Bordman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn L. Safford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdulgader S. Alarhayem, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark Glover, MD |
|
|
Dr. Aaron M. Lewis, DO |
|
|
Dr. Matthew J. McHale, DO |
|
|
Dr. Sayf A. Said, MD |
|
|
Dr. Matthew L. Voth, MD |
|
|
Dr. Georgios Voidonikolas, MD |
|
|
Thomas S. Deahl II |